FDA Releases Data Related to Philips Recalls
Posted on February 10, 2023 |
February 9, 2023 - The US Food and Drug Administration (FDA) issued a statement today related to the Philips Respironics recall of respiratory assist devices such as CPAP, BiPAP, and Trilogy machines. All device manufacturers are required to file medical device reports (MDRs) when they become aware that their devices have caused injury or death. To learn more about the MDRs filed by Philips Respironics, please visit the FDA website.
Patients and health care professionals can file voluntary reports for adverse reactions with the FDA through their respective links.